Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,464,886
+$211,093 QoQ
Shares Held
6,780
-0.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#393
of 1,031 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF HAWAII holds $33,752,794 across 11 Drug Manufacturers - General names. BIIB ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,030 | $9,150,539 | |
| 2 | LLY |
ELI LILLY & Co
|
5,999 | $7,195,380 | |
| 3 | ABBV |
AbbVie Inc.
|
27,871 | $7,013,457 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,915 | $5,000,577 | |
| 5 | BIIB |
Biogen Inc.
This page
|
6,780 | $1,464,886 | |
| 6 | PFE |
Pfizer Inc
|
41,818 | $1,006,977 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,468 | $718,406 | |
| 8 | NVO |
Novo Nordisk A S
|
14,016 | $671,927 |
All Filings in BIIB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,464,886 | 6,780 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,253,793 | 6,839 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,173,325 | 6,667 | Shares | Defined | 2026-03-03 | |
| 2023-06-30 | $965,641 | 3,390 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $934,458 | 3,361 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $790,606 | 2,855 | Shares | Defined | 2023-01-30 | |
| 2020-03-31 | $428,694 | 1,355 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||